DOCS — Doximity, Inc. stock price, charts and financials

NYSE·Healthcare·Medical - Healthcare Information Services·USA

Latest market price

26.11

-0.46-1.73%

Overview Short InterestFilings

DOCSQT48Doximity, Inc.·NYSE

Overview Short InterestFilings

26.11-1.73%

News

Down 1.7% — Kaplan Fox & Kilsheimer LLP Alerts Doximity, Inc. (DOCS) Investors to a Securities Class Action Deadline on November 16, 2026 (newsfilecorp.com).

Medium confidence

Loading chart...

Signal & projected range

Insider open-market saleHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

WAY-3.21%$25.66 HTFL+2.38%$50.75 HNGE+0.19%$94.90 HQY+0.67%$95.14 PRVA-1.19%$19.85 BTSG+0.32%$56.78 TEM-3.14%$77.84 OMCL-1.20%$32.23

Snapshot

Index	-	P/E	29.34	EPS (ttm)	0.89	Insider Own	30.26%	Shs Outstand	187.03M	Perf Week	2.07%

Market Cap	4.88B	Forward P/E	16.80	EPS next Y	1.55	Insider Trans	-0.06%	Shs Float	181.35M	Perf Month	1.40%

Enterprise Value	4.62B	PEG	-	EPS next Q	0.34	Inst Own	-	Short Float	7.75%	Perf Quarter	27.61%

Income	170.91M	P/S	7.45	EPS this Y	58.32%	Inst Trans	-	Short Ratio	2.99	Perf Half Y	5.28%

Sales	655.56M	P/B	5.20	EPS next Y	15.51%	ROA	15.41%	Short Interest	14.05M	Perf YTD	-41.03%

Book/sh	-	P/C	15.56	EPS next 5Y	11.10%	ROE	16.95%	52W High	76.50 -65.87%	Perf Year	-64.07%

Cash/sh	-	P/FCF	16.32	EPS past 3/5Y	22.74% 52.20%	ROIC	15.31%	52W Low	17.15 52.24%	Perf 3Y	21.27%

Dividend Est.	-	EV/EBITDA	18.95	Sales past 3/5Y	15.46% 25.52%	Gross Margin	88.07%	Volatility	3.85% 3.71%	Perf 5Y	-74.41%

Dividend TTM	-	EV/Sales	7.05	EPS Y/Y TTM	-23.42%	Oper. Margin	29.60%	ATR (14)	1.22	Perf 10Y	-

Dividend Ex-Date	-	Quick Ratio	6.08	Sales Y/Y TTM	15.09%	Profit Margin	25.48%	RSI (14)	54.79	Recom	2.67

Dividend Gr. 3/5Y	-	Current Ratio	6.08	EPS Q/Q	-23.68%	SMA20	1.40%	Beta	1.21	Target Price	27.36

Payout	0.00%	Debt/Eq	0.01	Sales Q/Q	7.53%	SMA50	8.81%	Rel Volume	1.53	Prev Close	26.57

Employees	880	LT Debt/Eq	0.01	Earnings	Nov 05	SMA200	-6.01%	Avg Volume	4.64M	Price	26.11

IPO Date	Jun 24, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	-4.27% 3.19%	Net Debt/EBITDA	-1.08	Volume	7,099,982	Change	-1.73%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Sep-08-26	Reiterated	Stifel Nicolaus		$27
Sep-08-26	Downgrade	Freedom Capital Markets	Buy → Hold
Aug-13-26	Reiterated	Truist Securities	Hold	$19 → $24
Aug-10-26	Downgrade	Wells Fargo	Equal Weight → Underweight
Aug-07-26	Reiterated	Needham	Buy	$27 → $41
Aug-07-26	Reiterated	BMO Capital	Market Perform	$20 → $30
Aug-07-26	Reiterated	Canaccord Genuity	Buy	$30 → $36
Aug-07-26	Reiterated	Evercore ISI Group	In Line	$81 → $40
Jun-29-26	Downgrade	B of A Securities	Buy → Underperform
May-15-26	Downgrade	Barclays	Overweight → Equal Weight	$20

Latest News· Times ET

Sep-18-26

Sep-18-2609:00AM

Kaplan Fox & Kilsheimer LLP Alerts Doximity, Inc. (DOCS) Investors to a Securities Class Action Deadline on November 16, 2026newsfilecorp.com

07:47AM

Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Doximity, Inc. (DOCS)newsfilecorp.com

03:30AM

Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – DOCSbusinesswire.com

Sep-17-26

Sep-17-2603:16PM

DOXIMITY, INC. (DOCS) INVESTOR ALERT Investors With Large Losses in Doximity, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rightsglobenewswire.com

03:11PM

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCSprnewswire.com

02:23PM

DOCS Shareholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Doximity, Inc.prnewswire.com

01:54PM

DOCS INVESTOR ALERT: Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead the Doximity Class Action Lawsuitprnewswire.com

12:00PM

DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Lawgurufocus.com

11:44AM

Portnoy Law Firm Announces Class Action on Behalf of Doximity, Inc. Investorsglobenewswire.com

10:20AM

DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuitprnewswire.com

08:00AM

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harmglobenewswire.com

06:48AM

Rosen Law Firm Urges Doximity, Inc. (NYSE: DOCS) Stockholders to Contact the Firm for Information About Their Rightsbusinesswire.com

Sep-16-26

Sep-16-2612:36PM

Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of Securities Class Action Lawsuit Against Doximity, Inc.businesswire.com

12:33PM

Investor Notice: Robbins LLP Informs Investors of the Doximity, Inc. Class Action Lawsuitbusinesswire.com

Sep-15-26

Sep-15-2603:15PM

Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Notezacks.com

Company

Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2026 3/31/2026	FY 2025 3/31/2025	FY 2024 3/31/2024	FY 2023 3/31/2023	FY 2022 3/31/2022	FY 2021 3/31/2021	FY 2020 3/31/2020	FY 2019 3/31/2019
Total Revenue	656	645	570	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	78	70	56	—	—	—	—	—	—
Gross Profit	577	575	515	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	241	229	191	—	—	—	—	—	—
Research and Development	142	131	93	—	—	—	—	—	—
Other Operating Expense	-1	0	3	—	—	—	—	—	—
Operating Income	195	215	228	—	—	—	—	—	—
Interest Expense	0	0	0	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	32	35	36	—	—	—	—	—	—
Net Income Before Taxes	226	250	264	—	—	—	—	—	—
Income Taxes	59	54	40	—	—	—	—	—	—
Consolidated Net Income	167	196	223	—	—	—	—	—	—
Net Income From Continuing Operations	167	196	223	—	—	—	—	—	—
Net Income	167	196	223	—	—	—	—	—	—
EPS (Recurring)	0.89	1.05	1.19	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	0.89	1.05	1.19	—	—	—	—	—	—
EPS (Diluted)	0.85	0.98	1.11	—	—	—	—	—	—
EBITDA	244	264	241	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	30.72	23.78	52.28	—	—	—	—	—	—
Price To Sales Ratio	7.28	6.76	19.04	—	—	—	—	—	—
Gross Margin	87.96	89.15	90.35	—	—	—	—	—	—
Operating Margin	29.73	33.33	40.00	—	—	—	—	—	—
Net Margin	25.46	30.39	39.12	—	—	—	—	—	—
Shares Outstanding	183	187	187	—	—	—	—	—	—
Market Capitalization	4,778	4,357	10,852	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Unlock with Premium

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sitaram Siddharth	Chief Accounting Officer	Sep 15 '26	Option Exercise	0.00	5,000	0	5,000	Sep 16
Sitaram Siddharth	Chief Accounting Officer	Sep 15 '26	Sale	26.02	2,077	54,044	96,045	Sep 16
Wampler Kira Scherer	Director	Sep 01 '26	Option Exercise	0.00	2,000	0	2,000	Sep 03
Wampler Kira Scherer	Director	Sep 01 '26	Sale	26.33	2,000	52,660	27,923	Sep 03
Wampler Kira Scherer	Director	Aug 25 '26	Option Exercise	0.00	2,000	0	2,000	Aug 27
Wampler Kira Scherer	Director	Aug 25 '26	Sale	24.95	2,000	49,900	19,839	Aug 27
Sitaram Siddharth	Chief Accounting Officer	Aug 13 '26	Option Exercise	0.00	5,000	0	5,000	Aug 17
Sitaram Siddharth	Chief Accounting Officer	Aug 13 '26	Sale	24.94	1,770	44,144	97,004	Aug 17
Cabral Timothy S	Director	Aug 07 '26	Option Exercise	0.00	7,500	0	7,500	Aug 11
Cabral Timothy S	Director	Aug 07 '26	Sale	39.11	7,500	293,325	3,221	Aug 11
Sitaram Siddharth	Chief Accounting Officer	Jul 15 '26	Option Exercise	0.00	4,800	0	4,800	Jul 20
Sitaram Siddharth	Chief Accounting Officer	Jul 15 '26	Sale	22.02	1,732	38,139	93,774	Jul 20
Sitaram Siddharth	Interim PAO	Jun 08 '26	Sale	20.41	2,444	49,882	90,706	Jun 10
Sitaram Siddharth	Interim PAO	Jun 08 '26	Option Exercise	0.00	5,000	0	5,000	Jun 10
Sitaram Siddharth	Interim PFO and PAO	May 11 '26	Sale	25.77	2,309	59,503	89,396	May 13

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.